JPS59141951A - 血漿分離装置 - Google Patents

Info

Publication number

JPS59141951A

JPS59141951A JP58014550A JP1455083A JPS59141951A JP S59141951 A JPS59141951 A JP S59141951A JP 58014550 A JP58014550 A JP 58014550A JP 1455083 A JP1455083 A JP 1455083A JP S59141951 A JPS59141951 A JP S59141951A

Authority

JP

Japan

Prior art keywords

plasma

blood

separator

discharge

storage tank

Prior art date

1983-02-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000926 separation method Methods 0.000 title claims description 21
• 210000002966 serum Anatomy 0.000 title 1
• 239000008280 blood Substances 0.000 claims description 79
• 210000004369 blood Anatomy 0.000 claims description 78
• 239000007788 liquid Substances 0.000 claims description 43
• 239000012528 membrane Substances 0.000 claims description 28
• 238000005406 washing Methods 0.000 claims description 10
• 210000002381 plasma Anatomy 0.000 description 153
• 238000001914 filtration Methods 0.000 description 16
• 230000017531 blood circulation Effects 0.000 description 13
• 230000001105 regulatory effect Effects 0.000 description 10
• 210000003462 vein Anatomy 0.000 description 9
• 230000037452 priming Effects 0.000 description 7
• 108010085603 SFLLRNPND Proteins 0.000 description 5
• 210000001367 artery Anatomy 0.000 description 5
• 238000004140 cleaning Methods 0.000 description 5
• 239000012530 fluid Substances 0.000 description 5
• 238000000034 method Methods 0.000 description 5
• 239000002504 physiological saline solution Substances 0.000 description 5
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 210000000601 blood cell Anatomy 0.000 description 3
• 230000000694 effects Effects 0.000 description 2
• 239000000706 filtrate Substances 0.000 description 2
• 239000012510 hollow fiber Substances 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 238000007789 sealing Methods 0.000 description 2
• 239000003566 sealing material Substances 0.000 description 2
• 230000001954 sterilising effect Effects 0.000 description 2
• 238000004659 sterilization and disinfection Methods 0.000 description 2
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 239000005038 ethylene vinyl acetate Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 229920003049 isoprene rubber Polymers 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 229920001684 low density polyethylene Polymers 0.000 description 1
• 239000004702 low-density polyethylene Substances 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• -1 organic acid esters Chemical class 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 238000005191 phase separation Methods 0.000 description 1
• 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
• 239000004417 polycarbonate Substances 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 239000005060 rubber Substances 0.000 description 1
• 229920003048 styrene butadiene rubber Polymers 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 229920003002 synthetic resin Polymers 0.000 description 1
• 239000000057 synthetic resin Substances 0.000 description 1

Cited By (2)